|
Re: Medtronic takes '1st step' toward U.S. sale of artificial pancreas
|
|
Mannkind
|
Jun 24, 2013 07:01PM
|
|
Oramed(again)
|
|
Mannkind
|
Jun 25, 2013 10:03AM
|
|
Re: Trial results
|
4
|
Mannkind
|
Jun 25, 2013 11:23AM
|
|
Re: Trial results
|
|
Mannkind
|
Jun 25, 2013 01:58PM
|
|
Re: Warrants vs. shares calculation
|
|
Mannkind
|
Jun 25, 2013 04:07PM
|
|
Re: Trial results
|
1
|
Mannkind
|
Jun 25, 2013 04:20PM
|
|
Re: Trial results
|
|
Mannkind
|
Jun 25, 2013 06:03PM
|
|
Watch for MannKind to Potentially Rebound After Falling 3.18% Yesterday
|
|
Mannkind
|
Jun 25, 2013 07:19PM
|
|
Re: Watch for MannKind to Potentially Rebound After Falling 3.18% Yesterday
|
|
Mannkind
|
Jun 25, 2013 07:23PM
|
|
Re: ISIS performance profile Pharma Comparison
|
|
Mannkind
|
Jun 25, 2013 11:36PM
|
|
Re: New SA Article
|
|
Mannkind
|
Jun 27, 2013 09:14AM
|
|
Re: New SA Article
|
|
Mannkind
|
Jun 27, 2013 10:14AM
|
|
Re: New SA Article
|
8
|
Mannkind
|
Jun 27, 2013 11:24AM
|
|
Re: New SA Article
|
|
Mannkind
|
Jun 27, 2013 01:33PM
|
|
Re: New SA Article
|
1
|
Mannkind
|
Jun 27, 2013 06:57PM
|
|
Lyxumia® is First Diabetes Therapy of its Class Approved in Japan for use in Com
|
|
Mannkind
|
Jun 28, 2013 09:03AM
|
|
Re: Lyxumia® is First Diabetes Therapy of its Class Approved in Japan for use in Com
|
1
|
Mannkind
|
Jun 28, 2013 10:20AM
|
|
Who Really, Really Wants Some More Pfizer Stock?
|
1
|
Mannkind
|
Jun 29, 2013 06:44PM
|
|
Starting Insulin for Type 2 Diabetes: When, Why,
|
1
|
Mannkind
|
Jun 30, 2013 12:30PM
|
|
Re: MannKind announces $160M debt financing
|
1
|
Mannkind
|
Jul 01, 2013 12:51PM
|
